Last reviewed · How we verify

NCT06146595

Prevalence of Attention Deficit Hyperactivity Disorder and Its Comorbidities

Status unknown Last updated 24 November 2023
What this trial tests

trial in ADHD in 200 participants. Status unknown.

Timeline
1 February 2024
Primary endpoint
1 September 2025
1 November 2025

Quick facts

Lead sponsorAssiut University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment200
Start date1 February 2024
Primary completion1 September 2025
Estimated completion1 November 2025

Conditions studied

Sponsor

Assiut University

Who can join

Adults 6 to 17, any sex, with ADHD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Estimate the prevalence of attention deficit hyperactivity disorder and comorbid psychiatric disorder among primary school students in New Valley governorate.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for ADHD

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06146595.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing